Which treatment for which tumor?
Diagnosis Guide
Lymphoma
In lymphoma, chemotherapy and immunotherapy are strong standards; for refractory/relapsed B-cell lymphomas, CAR-T cell therapy is a licensed and established option in Japan.
What to Know About This Diagnosis
CAR-T is a cell therapy with demonstrated efficacy in relapsed B-cell lymphoma.
iPSC-derived 'off-the-shelf' cell programs (iCART) are an investigational approach aiming to shorten waiting time.
Evaluation is based on lymphoma subtype and prior treatment responses.
Important Note
Lymphoma subtypes behave very differently; your file is reviewed by the hematology expert board.